Accord Takes On Ustekinumab Rivals In US With Steepest Discount Yet

Imuldosa Version Launched At 92% Discount To Stelara’s WAC

 
• By Dave Wallace
  
Accord BioPharma is offering a 92% discount to Stelara (Shutterstock)

More from Strategy

More from Business